Last €23.62 EUR
Change Today +0.149 / 0.63%
Volume 660.0
PHIA On Other Exchanges
Symbol
Exchange
New York
EN Amsterdam
OTC US
Xetra
BrsaItaliana
EN Amsterdam
As of 9:52 AM 09/22/14 All times are local (Market data is delayed by at least 15 minutes).

koninklijke philips nvr- ny (PHIA) Snapshot

Open
€23.28
Previous Close
€23.47
Day High
€24.00
Day Low
€23.28
52 Week High
01/17/14 - €28.62
52 Week Low
05/5/14 - €21.66
Market Cap
22.2B
Average Volume 10 Days
90.4
EPS TTM
--
Shares Outstanding
937.8M
EX-Date
05/5/14
P/E TM
--
Dividend
€1.01
Dividend Yield
3.32%
Current Stock Chart for KONINKLIJKE PHILIPS NVR- NY (PHIA)

Related News

No related news articles were found.

koninklijke philips nvr- ny (PHIA) Details

Koninklijke Philips N.V. is engaged in healthcare, consumer lifestyle, and lighting businesses worldwide. Its healthcare solutions include radiation oncology, clinical applications and platforms, and portfolio management; advanced diagnostic imaging, such as computed tomography (CT), magnetic resonance imaging (MRI), and molecular imaging; digital X-ray and mammography; interventional X-rays; ultrasound products; enterprise patient monitoring solutions for clinical information at the patient’s bedside; cardiology informatics and enterprise imaging informatics; patient monitoring and clinical informatics; mother and child care products; therapeutic care products; sleep management, respiratory care, and non-invasive ventilation; medical alert and medication dispensing services; remote patient monitoring; and equipment services and support, equipment financing and asset management, and professional services. The company's consumer lifestyle solutions consist of mother and childcare, oral healthcare, pain management, male grooming, and beauty products; and kitchen appliances, coffee, garment care, floor care, and air purification products. Its lighting solutions include light sources and electronics, such as LED, eco-halogen, fluorescent, discharge, and incandescent light sources, as well as electronic and electromagnetic gears, modules, and drivers; consumer luminaires, including functional, decorative, lifestyle, and scene-setting luminaires; professional lighting solutions, such as controls and luminaires for city beautification, road lighting, sports lighting, office lighting, shop/hospitality lighting, and industry lighting; automotive lighting products; and packaged LEDs. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Founded in 1891

koninklijke philips nvr- ny (PHIA) Top Compensated Officers

Chairman of the Board of Management, Chief Ex...
Total Annual Compensation: €2.2M
Chief Financial Officer, Executive Vice-Presi...
Total Annual Compensation: €1.2M
Executive Vice-President, Chief Executive Off...
Total Annual Compensation: €1.2M
Compensation as of Fiscal Year 2013.

koninklijke philips nvr- ny (PHIA) Key Developments

Ion Beam Applications S.A. and Royal Philips Collaborate on Diagnosis and Treatment of Cancer

Ion Beam Applications S.A., or IBA and Royal Philips have signed a global collaboration agreement to provide diagnostic and therapeutic solutions for the treatment of cancer. The collaboration covers sales, marketing, R&D of imaging and therapy solutions in oncology. By merging their respective expertise in therapy and image guidance systems, IBA and Philips will innovate with an integrated vision for more efficient, personalized cancer care. Leveraging high quality imaging and proton therapy offers the potential to increase confidence in the diagnosis and treatment of cancer, reduce short- and long-term side-effects and potentially enhance the quality of life of the patient before, during and after treatment, while reducing the cost of treatment for the healthcare system. The collaboration will also enable both organizations to mutually leverage technologies and solutions: IBA will benefit from Philips diagnostic imaging products offered to oncology care centers, while Philips will leverage IBA proton therapy solutions within its offering for customers in select markets around the world. The commercial collaboration also includes an integrated offering for Molecular Imaging Centers, combining IBA's expertise in PET radioisotope production centers with Philips imaging and diagnostics expertise.

Royal Philips Demonstrates Commitment to Radiation Oncology Solutions at Astro 2014

Royal Philips announced a number of innovations at ASTRO's 56th Annual Meeting in San Francisco, showcasing solutions that increase workflow automation, confidence, consistency and accuracy in cancer treatment. Producing quality results in less time and enhancing patient-centric care, these radiation oncology solutions underscore Philips' dedication to leading healthcare into an era of a more personalized approach to medicine. The Philips booth (#1128) at ASTRO 2014 will showcase the company's expanding oncology presence with a suite of options for physicians and clinicians to target various cancers and improve care for patients. Key product offerings highlighted at ASTRO include: Pinnacle3 Auto-Planning -- Pinnacle(3) Auto-Planning is designed to simplify and accelerate IMRT & VMAT planning. It has smart automation tools that enable the user to generate high quality plans quickly, and with limited intervention. These plans can then be evaluated against agreed clinical goals using intuitive dashboards, called Scorecards that provide at-a-glance information regarding plan quality, facilitating consistency of treatments throughout the department; iPatient Platform for Brilliance CT Big Bore-- Philips is continuing to focus on innovations that facilitate patient-centered imaging by expanding its advanced iPatient platform to the Brilliance CT Big Bore. iPatient puts users in control of innovative solutions that drive confidence and consistency through a personalized, patient-centric workflow. It helps health systems reap more from their investments by allowing users the ability to focus complex and advanced procedures; Works-in-progress: MRI-Only Simulation for Prostate - Philips is designing a plug-in extension to its Ingenia MR-RT Oncology Configuration. The software package is intended to include embedded auto-segmentation and bulk density assignment algorithms to provide CT-like MR images, with the possibility of uploading to treatment planning systems to aid in dose calculations. The first application planned is prostate, which is one of the main applications to harness MRI's soft-tissue contrast for RT planning purposes.

Royal Philips Announces Launch of New Affiniti Ultrasound System

Royal Philips has announced the launch of Affiniti, a new ultrasound system reportedly designed to provide technology to help radiology/ultrasound departments facing more patients with fewer resources. Built on the same architecture as Philips' ground breaking EPIQ ultrasound, Affiniti meets the needs of physicians who are challenged with treating large volumes of patients on any given day. Philips collaborated with hundreds of physicians around the world, who provided feedback to help inform Affiniti's ergonomic design, which led to an intuitive, easy-to-use system. Philips put the system through 4,500 hours of reliability testing with the demands of a busy medical practice and heavy workload in mind. Key features include: Crisp, clear images that enable fast, confident diagnosis and reduce the need for additional exams; Philips' PureWave transducer technology, delivering excellent image quality with little or no need for image adjustment for technically difficult patients; Anatomical Intelligent Ultrasound, providing automatic anatomy recognition and quantification, making it easy to perform exams and quickly deliver new levels of clinical information; Automation tools such as AutoSCAN, Auto Doppler and SmartExam to reduce the number of steps required to complete each exam, resulting in enhanced workflow; and DICOM and PC format capabilities to allow seamless information-sharing. Affiniti is not yet available for sale, but will be available in several European markets later this year, with the US launch slated for 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PHIA:GR €23.62 EUR +0.149

PHIA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for PHIA.
View Industry Companies
 

Industry Analysis

PHIA

Industry Average

Valuation PHIA Industry Range
No financial data is available for PHIA.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact KONINKLIJKE PHILIPS NVR- NY, please visit www.philips.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.